Scrying Biotech
Long only, biotech, micro-cap, small-cap

Thank You For Riding The MannKind Catalyst Train - Please Exit Safely At The Next Available Station

The biotechnology sector of the stock market has one singularly unique aspect that differentiates it from any other sector - the FDA Advisory Committee Meeting, or Adcom, as it's commonly abbreviated. According to the FDA website, Adcoms are "committees and panels to obtain independent expert advice on scientific, technical and policy matters." But to companies that face them, they're perilous dates with destiny that almost always end in disappointment, conclusively determining the fate of a company's commercial product candidate and consequently, the size of a shareholder's remaining position in that company. Because of this, adcoms have become the very definition of the binary event which has one of only two possible outcomes - very positive or very negative.

Last year,...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details